Variant report
Variant | esv3428581 |
---|---|
Chromosome Location | chr2:51534048-51536046 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115237662 | chr2:51534246-51534247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371973220 | chr2:51534248-51534249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375303624 | chr2:51534254-51534255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs12233091 | chr2:51534306-51534307 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs13402444 | chr2:51534381-51534382 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs535562812 | chr2:51534383-51534384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs62142879 | chr2:51534577-51534578 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs62142880 | chr2:51534593-51534594 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs147115132 | chr2:51534803-51534804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs557878538 | chr2:51534817-51534818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62142883 | chr2:51534836-51534837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs528787673 | chr2:51534843-51534844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547051103 | chr2:51534869-51534870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6729654 | chr2:51534914-51534915 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs529259325 | chr2:51534983-51534984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550811870 | chr2:51534993-51534994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs59452147 | chr2:51535025-51535026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72832170 | chr2:51535037-51535038 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs369818130 | chr2:51535048-51535049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369434368 | chr2:51535096-51535097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188794748 | chr2:51535101-51535102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6761590 | chr2:51535148-51535149 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs533817356 | chr2:51535157-51535158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555367023 | chr2:51535210-51535211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs74331856 | chr2:51535275-51535276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373085825 | chr2:51535279-51535280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181947597 | chr2:51535299-51535300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555990399 | chr2:51535313-51535314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577379765 | chr2:51535317-51535318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138516188 | chr2:51535318-51535319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546460539 | chr2:51535334-51535335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564656294 | chr2:51535336-51535337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148828456 | chr2:51535337-51535338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538949649 | chr2:51535350-51535351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558850462 | chr2:51535389-51535390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116803371 | chr2:51535414-51535415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562371029 | chr2:51535429-51535430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369073609 | chr2:51535468-51535469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13392665 | chr2:51535469-51535470 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs559989833 | chr2:51535471-51535472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113820176 | chr2:51535504-51535505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562887304 | chr2:51535513-51535514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141701986 | chr2:51535531-51535532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573650108 | chr2:51535582-51535583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551193279 | chr2:51535601-51535602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566306859 | chr2:51535613-51535614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533707727 | chr2:51535650-51535651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549019118 | chr2:51535652-51535653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529179517 | chr2:51535701-51535702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555087098 | chr2:51535720-51535721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51534200-51534600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:51534200-51534600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr2:51534800-51537000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |